Home › NDC Lookup › RxCUI directory › RxCUI 351926

Insulin aspart, human 100 UNT/ML Injectable Solution [NovoLog] — RxCUI 351926

Name: Insulin aspart, human 100 UNT/ML Injectable Solution [NovoLog] (RxCUI 351926)
Creator: Brian Staiger, PharmD

RxNorm drug concept · Semantic branded drug

RxCUI 351926 Semantic branded drug · SBD ● Current RxNorm concept 9 FDA products 12 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by Dr. Brian Staiger, PharmD

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI351926

Official nameInsulin aspart, human 100 UNT/ML Injectable Solution [NovoLog]

Concept typeSemantic branded drug (SBD)

RxNorm statusCurrent RxNorm concept

Also known asNovoLog 100 UNT/ML Injectable Solution

FDA products mapped9

Package NDCs mapped12

Reported Medicaid activity (SDUD)325,588 prescriptions · 52 state & territory Medicaid programs · latest period Q4 2025

RxNorm release07/06/2026

Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Insulin Aspart (rDNA Origin) Injection: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist

Insulin aspart is a man-made, rapid-acting insulin that is very similar to the insulin your body makes naturally, but it works faster. After you inject it under the skin, it starts...
What exactly is insulin aspart and how is it different from regular insulin?
Generally, you should inject it within about 5 to 10 minutes before a meal so it starts working as your blood sugar begins to rise from food. The exact timing depends on which prod...
When should I inject insulin aspart — before or after eating?

📖 Read our full Insulin Aspart (rDNA Origin) Injection guide →

🕸️ Concept Web — How Insulin aspart, human 100 UNT/ML Injectable Solu... Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.

This page's concept Insulin aspart, human 100 UNT/ML Injectable Solution [NovoLog] RxCUI 351926 Semantic branded drug · SBD

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

Ingredients 1

The active substance itself — no strength, form, or brand attached yet.
- Insulin aspart, human 51428 IN
Brand names 1

The same medicine's trade names. A brand name alone says nothing about strength or form.
- NovoLog 284810 BN
Dose forms 6

The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.
- Insulin aspart, human Injectable Solution 378914 SCDF
- Insulin aspart, human Injectable Product 1157463 SCDG
- Insulin aspart, human Injectable Solution [NovoLog] 363534 SBDF
- NovoLog Injectable Product 1178119 SBDG
- Injectable Solution 316949 DF
- Injectable Product 1151126 DFG
Clinical & branded drugs 3

Ingredient + strength + dose form. These are the concepts real FDA products actually carry.
- Insulin aspart, human 100 UNT/ML Injectable Solution 311040 SCD
- Insulin aspart, human 100 UNT/ML 343211 SCDC
- Insulin aspart, human 100 UNT/ML [NovoLog] 575679 SBDC

Showing up to 8 concepts per family — 11 of 11 stored related concepts drawn.

These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

Insulin aspart, human 100 UNT/ML Injectable Solution SCD · 311040
Insulin aspart, human 100 UNT/ML SCDC · 343211
Insulin aspart, human Injectable Solution SCDF · 378914
Insulin aspart, human Injectable Product SCDG · 1157463

Brand-Name Concepts

Insulin aspart, human 100 UNT/ML [NovoLog] SBDC · 575679
Insulin aspart, human Injectable Solution [NovoLog] SBDF · 363534
NovoLog Injectable Product SBDG · 1178119
NovoLog BN · 284810

📦 FDA Products & Package NDCs

9 products · 12 package NDCs

12 package NDCs map to RxCUI 351926 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.

Package NDC	Package	Brand / generic name	Labeler	Marketing start
00169-2001-90	1 VIAL, GLASS in 1 CARTON (0169-2001-90) / 10 mL in 1 VIAL,...	Insulin Diluting Medium for NovoLog	Novo Nordisk	2018-08-01
00169-2100-11	1 VIAL, GLASS in 1 CARTON (0169-2100-11) / 10 mL in 1 VIAL,...	NOVOLOG	Novo Nordisk	2021-05-25
00169-2101-25	5 SYRINGE, PLASTIC in 1 CARTON (0169-2101-25) / 3 mL in 1 S...	NOVOLOG	Novo Nordisk	2021-05-25
00169-3303-12	5 CARTRIDGE in 1 CARTON (0169-3303-12) / 3 mL in 1 CARTRIDG...	NOVOLOG	Novo Nordisk	2001-08-27
00169-3303-90	5 CARTRIDGE in 1 CARTON (0169-3303-90) / 3 mL in 1 CARTRIDG...	NOVOLOG	Novo Nordisk	2001-08-27
00169-3303-91	1 CARTRIDGE in 1 CARTON (0169-3303-91) / 3 mL in 1 CARTRIDG...	NOVOLOG	Novo Nordisk	2001-08-27
00169-6339-10	5 SYRINGE, PLASTIC in 1 CARTON (0169-6339-10) / 3 mL in 1 S...	NOVOLOG	Novo Nordisk	2003-01-22
00169-6339-98	1 SYRINGE, PLASTIC in 1 CARTON (0169-6339-98) / 3 mL in 1 S...	NOVOLOG	Novo Nordisk	2003-01-22
00169-7501-11	1 VIAL, GLASS in 1 CARTON (0169-7501-11) / 10 mL in 1 VIAL,...	NOVOLOG	Novo Nordisk	2001-08-27
00169-7501-90	1 VIAL, GLASS in 1 CARTON (0169-7501-90) / 10 mL in 1 VIAL,...	NOVOLOG	Novo Nordisk	2001-08-27
50090-1664-00	1 VIAL, GLASS in 1 CARTON (50090-1664-0) / 10 mL in 1 VIAL,...	NOVOLOG	A-S Medication Solutions	2015-01-23
50090-1678-00	5 SYRINGE, PLASTIC in 1 CARTON (50090-1678-0) / 3 mL in 1 S...	NOVOLOG	A-S Medication Solutions	2015-01-30

Observed labelers: Novo Nordisk (10) · A-S Medication Solutions (2) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🧾 Billing Codes (HCPCS)

Medical billing codes (HCPCS "J-codes") that connect to this concept's packages — used mostly when a clinic or hospital bills for a drug it administers. Each code links to its full billing page.

Code	Descriptor	Mapped packages	Sources
J1817	Insulin for insulin pump use	7	CMS

⚠ A crosswalk is not coverage: an NDC↔HCPCS mapping does not guarantee any payer covers or pays the code. Always verify the current payer policy before billing.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7

openFDA export observedJul 14, 2026

RxNorm release07/06/2026

Methodology2026-07-full-catalog-v1

A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.

This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.